News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
247,723 Results
Type
Article (11829)
Company Profile (22)
Press Release (235872)
Section
Business (88931)
Career Advice (496)
Deals (13746)
Drug Delivery (18)
Drug Development (30591)
Employer Resources (54)
FDA (6209)
Job Trends (5291)
News (139887)
Policy (11150)
Tag
Academia (886)
Alliances (16852)
Alzheimer's disease (435)
Approvals (6214)
Artificial intelligence (51)
Bankruptcy (79)
Best Places to Work (4388)
Breast cancer (58)
Cancer (458)
Cardiovascular disease (35)
Career advice (417)
Cell therapy (73)
Clinical research (25251)
Collaboration (146)
COVID-19 (620)
C-suite (44)
Data (498)
Diabetes (76)
Diagnostics (2332)
Earnings (45856)
Employer resources (48)
Events (34416)
Executive appointments (109)
FDA (6416)
Funding (82)
Gene therapy (51)
GLP-1 (179)
Government (1186)
Healthcare (6378)
Infectious disease (651)
Inflammatory bowel disease (51)
Interviews (69)
IPO (6459)
Job creations (1114)
Job search strategy (388)
Layoffs (89)
Legal (2280)
Lung cancer (85)
Manufacturing (47)
Medical device (5581)
Medtech (5582)
Mergers & acquisitions (7318)
Metabolic disorders (151)
Neuroscience (516)
NextGen Class of 2024 (1976)
Non-profit (1459)
Northern California (498)
Obesity (81)
Opinion (43)
Parkinson's disease (32)
People (22689)
Phase I (6719)
Phase II (10774)
Phase III (9433)
Pipeline (238)
Postmarket research (1145)
Preclinical (2781)
Radiopharmaceuticals (107)
Rare diseases (64)
Real estate (1784)
Regulatory (8153)
Research institute (837)
Resumes & cover letters (72)
Southern California (463)
Startups (1087)
United States (4368)
Vaccines (126)
Weight loss (41)
Date
Today (39)
Last 7 days (280)
Last 30 days (1439)
Last 365 days (12733)
2024 (11750)
2023 (14916)
2022 (20712)
2021 (21775)
2020 (20275)
2019 (17327)
2018 (13207)
2017 (13567)
2016 (12348)
2015 (15256)
2014 (10902)
2013 (8488)
2012 (9321)
2011 (9774)
2010 (8719)
Location
Africa (275)
Arizona (37)
Asia (16495)
Australia (2908)
California (1085)
Canada (427)
China (115)
Colorado (39)
Connecticut (42)
Delaware (34)
Europe (46116)
Florida (158)
Georgia (52)
Illinois (98)
Indiana (80)
Japan (47)
Maine (32)
Maryland (178)
Massachusetts (788)
Michigan (56)
Minnesota (93)
New Jersey (384)
New York (285)
North Carolina (248)
Northern California (498)
Ohio (52)
Pennsylvania (259)
South America (482)
Southern California (463)
Texas (123)
Utah (30)
Washington State (112)
247,723 Results for "endo international plc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Endo Reports Fourth-Quarter 2023 Financial Results
Endo International plc reported financial results for the fourth-quarter ended December 31, 2023.
March 6, 2024
·
34 min read
Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS®
Endo International plc (OTC: ENDPQ) announced today that one of its operating companies, Par Pharmaceutical, Inc., launched ibuprofen-famotidine 800 mg/26.6 mg tablets, a generic version of Amgen’s (formerly Horizon Therapeutics) DUEXIS®.
March 26, 2024
·
13 min read
Endo’s Paladin Labs Announces Launch of XCOPRI® (cenobamate tablets) in Canada
Paladin Labs Inc., a subsidiary of Endo International plc (OTC: ENDPQ), announced today that XCOPRI® (cenobamate tablets) is now available in Canada.
January 22, 2024
·
7 min read
Pharm Country
Endo Announces Commencement of OTCQX Trading
Endo, Inc. announced that the Company has commenced trading on the OTCQX® Best Market under the ticker symbol NDOI.
June 28, 2024
·
3 min read
Endo Announces New Data for Dupuytren’s Contracture Presented at the American Association for Hand Surgery Annual Meeting
Endo International plc (OTC: ENDPQ) announced today that two new presentations related to Dupuytren’s contracture and XIAFLEX ® (collagenase clostridium histolyticum) were shared during the American Association for Hand Surgery (AAHS) annual meeting.
January 19, 2024
·
8 min read
Press Releases
Endo Reports Third-Quarter 2024 Financial Results and Reaffirms 2024 Financial Expectations
November 5, 2024
·
28 min read
Endo Announces Publication of New XIAFLEX® (collagenase clostridium histolyticum) Survey Data in Journal of Hand Surgery Global Open
Endo International plc (OTC: ENDPQ) announced today that the peer-reviewed Journal of Hand Surgery Global Open published Collagenase Clostridium Histolyticum for the Treatment of Dupuytren Disease: A Delphi-Based Consensus Study.
January 24, 2024
·
10 min read
Press Releases
Endo Announces CEO Transition
August 27, 2024
·
5 min read
Press Releases
Endo Announces Agreement for Paladin Pharma to Commercialize Wynzora® Cream in Canada
November 15, 2024
·
4 min read
Business
InnoGI Technologies Announces The Appointment Of Dr. Hajime Endo, Former Chairman And President Of Lonza Japan And JIHFS Board Member, As Strategic Commercial Advisor
InnoGI Technologies, a pioneer and leader in innovative gastrointestinal research, proudly announces the appointment of Dr. Hajime Endo as its Strategic Commercial Advisor.
June 25, 2024
·
3 min read
1 of 24,773
Next
